Skip to content
Cryptos: 553Market Cap: $2.87T 1.3%24h Vol: $129.14BDominance: BTC 58.1% ETH 10.5%
Open Tradzy

New high · Canada stocks

AbbVie Inc. (ABBV) closes at a 3-month high of CAD 39.65

Its second new 3-month high in 5 sessions. Up 7.8% over 20 sessions.

Published 16 October 2026 · Written from Tradzy's price and volume data

Close
CAD 39.65
On the day
+0.8%
Volume
0.1× average
vs 3-month high
New high

AbbVie Inc. closing prices

CAD 34.00CAD 36.00CAD 38.00CAD 40.00Jul 17Aug 5Aug 24Sep 10Sep 29Oct 16CAD 39.65

The last 63 closes up to 16 October 2026. The live chart is on the ABBV page.

What happened

AbbVie Inc. (ABBV) closed at CAD 39.65 on 16 October 2026, up 0.8% from CAD 39.32 the session before.

It is the second new high in the last 5 sessions. Over 5 sessions the price is up 5.1%, and over 20 sessions it is up 7.8%.

That close is above every close of the past 3 months. The previous highest was CAD 39.41 on 14 Oct 2026, and the new close is 0.6% above it.

Trading was light: volume was 7% of its recent average.

Across the 9 CBOECA stocks we track, 3 closed higher and 6 closed lower that day, with a median change of −1.31%. ABBV's change was +0.8%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeCAD 39.32
CloseCAD 39.65
Change on the day+0.84%
Change over 5 sessions+5.06%
Change over 20 sessions+7.83%
Volume300
Average volume, up to 20 sessions before4,599
Volume against that average0.1 times
Highest close in the past 3 monthsCAD 39.41 (14 Oct 2026)
Lowest close in the past 3 monthsCAD 33.89 (4 Aug 2026)

The full chart and history are on AbbVie Inc. (ABBV). More from this market: CBOECA news today.

More CBOECA moves on 16 October 2026

Want a plan for ABBV? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.